Research ArticleArticle
Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal Crisis
Edward P. Stern, Sandra G. Guerra, Harry Chinque, Vanessa Acquaah, David González-Serna, Markella Ponticos, Javier Martin, Voon H. Ong, Korsa Khan, Svetlana I. Nihtyanova, Mark Harber, Aine Burns, Maureen D. Mayes, Shervin Assassi, Carmen Fonseca and Christopher P. Denton
The Journal of Rheumatology March 2020, jrheum.190945; DOI: https://doi.org/10.3899/jrheum.190945
Edward P. Stern
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Sandra G. Guerra
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Harry Chinque
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Vanessa Acquaah
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
David González-Serna
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Markella Ponticos
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Javier Martin
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Voon H. Ong
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Korsa Khan
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Svetlana I. Nihtyanova
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Mark Harber
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Aine Burns
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Maureen D. Mayes
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Shervin Assassi
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Carmen Fonseca
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Christopher P. Denton
This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society). E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA. E.P. Stern and S.G. Guerra are joint first authors. Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk. Accepted for publication February 28, 2020.
Article Information
jrheum.190945
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online September 15, 2020.
Article Versions
- Latest version (March 15, 2020 - 04:00).
- You are currently viewing a Latest version of this article (September 15, 2020 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2020 The Journal of Rheumatology
Author Information
- Edward P. Stern,
- Sandra G. Guerra,
- Harry Chinque,
- Vanessa Acquaah,
- David González-Serna,
- Markella Ponticos,
- Javier Martin,
- Voon H. Ong,
- Korsa Khan,
- Svetlana I. Nihtyanova,
- Mark Harber,
- Aine Burns,
- Maureen D. Mayes,
- Shervin Assassi,
- Carmen Fonseca and
- Christopher P. Denton
- This study was supported in part by Medical Research Council grant MR/K015230/1 with additional support from a research grant from Scleroderma and Raynaud’s UK (formerly The Scleroderma Society).
E.P. Stern, MRCP, University College London (UCL) Centre for Rheumatology and Connective Tissue Diseases, and UCL Centre for Nephrology, London; S.G. Guerra, PhD, H. Chinque, BSc, V. Acquaah, BSc, M. Ponticos, V.H. Ong, PhD, FRCP, K. Khan, BSc, S.I. Nihtyanova, MD, C. Fonseca, MD, C.P. Denton, PhD, FRCP, Professor of Experimental Rheumatology, UCL Centre for Rheumatology and Connective Tissue Diseases, London, UK; D. González-Serna, PhD, J. Martin, MD, Instituto de Parasitologia y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain; M. Harber, FRCP, A. Burns, MD, UCL Centre for Nephrology, London, UK; M.D Mayes, MD, S. Assassi, MD, University of Texas Houston – McGovern Medical School, Houston, Texas, USA.
E.P. Stern and S.G. Guerra are joint first authors.
Address correspondence to Prof. C.P. Denton, UCL Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Building, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: c.denton@ucl.ac.uk.
Accepted for publication February 28, 2020.
Article usage
Statistics from Altmetric.com
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal Crisis
Edward P. Stern, Sandra G. Guerra, Harry Chinque, Vanessa Acquaah, David González-Serna, Markella Ponticos, Javier Martin, Voon H. Ong, Korsa Khan, Svetlana I. Nihtyanova, Mark Harber, Aine Burns, Maureen D. Mayes, Shervin Assassi, Carmen Fonseca, Christopher P. Denton
The Journal of Rheumatology Mar 2020, jrheum.190945; DOI: 10.3899/jrheum.190945
Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal Crisis
Edward P. Stern, Sandra G. Guerra, Harry Chinque, Vanessa Acquaah, David González-Serna, Markella Ponticos, Javier Martin, Voon H. Ong, Korsa Khan, Svetlana I. Nihtyanova, Mark Harber, Aine Burns, Maureen D. Mayes, Shervin Assassi, Carmen Fonseca, Christopher P. Denton
The Journal of Rheumatology Mar 2020, jrheum.190945; DOI: 10.3899/jrheum.190945